Patents Assigned to Message Pharmaceutical, Inc.
  • Patent number: 7078171
    Abstract: Described herein are methods for identifying novel nucleic acid regulatory elements and compounds that modulate the regulation of such elements. Also described herein are nucleic acid sequence identified as novel nucleic acid regulatory elements and host cells containing such nucleic acid regulatory elements in a vector.
    Type: Grant
    Filed: April 30, 2001
    Date of Patent: July 18, 2006
    Assignee: Message Pharmaceutical, Inc.
    Inventors: Anthony Giordano, Paul S. Eder, Deborah Beach McGill, Gregg Johannes
  • Patent number: 6465176
    Abstract: Disclosed are nucleic acid sequences which, when present in an RNA molecule, bind to RNA binding proteins. These nucleic acid sequences are present in untranslated regions of certain mRNA. They can be used in assays to identify compounds that affect the interaction of RNA containing the nucleic acid sequence, such as the source mRNA, and RNA binding proteins. The disclosed nucleic acid sequences can also be used to identify RNA binding proteins that can interact with the sequences. An assay for identifying compounds that affect interaction of RNA containing one of the disclosed nucleic acid sequences and RNA binding proteins is also disclosed. The assay involves detecting interactions between RNA binding proteins and an RNA molecule containing one of the disclosed nucleic acid sequences in the presence of a test compound and in the absence of the test compound. A difference in the detected interaction in the presence and absence of the test compound indicates that the compound affects the interaction.
    Type: Grant
    Filed: October 2, 1998
    Date of Patent: October 15, 2002
    Assignee: Message Pharmaceuticals, Inc.
    Inventors: Tony Giordano, Deborah L. Beach, Gretchen L. Temeles